On Feb. 1, Johns Hopkins and the United Arab Emirates Embassy in Washington, D.C., announced a new institute for stroke research and clinical care funded by a $50 million gift from the UAE.
The Sheikh Khalifa Stroke Institute will enable top clinician-scientists at Johns Hopkins to build on their pioneering work in neurology and neurosurgery, leveraging advances in biomedical engineering, artificial intelligence, and precision medicine to better diagnose, treat, and restore function to stroke patients.
The gift, believed to be the largest ever for a stroke-specific initiative, was announced this afternoon at an event in New York City, where speakers included Johns Hopkins University President Ronald J. Daniels; Paul Rothman, dean of JHU’s medical faculty and CEO of Johns Hopkins Medicine; philanthropist, Johns Hopkins alumnus, and former New York City Mayor Michael R. Bloomberg; and Yousef Al Otaiba, UAE Ambassador to the U.S.
“We are grateful for the UAE’s gift, which enables us to leverage our considerable strengths in neurology, physical medicine, and rehabilitation—in combination with our expertise in biomedical engineering and patient safety—to develop new tools for stroke diagnosis, treatment, and recovery,” Rothman says. “These efforts will improve the health of millions of people in Baltimore, the UAE, and around the world.”
Read more about the Sheikh Khalifa Stroke Institute on The Hub.
Interested in supporting life-saving initiatives like the Sheikh Khalifa Stroke Institute at Hopkins?
Topics: Friends of Johns Hopkins Medicine, Johns Hopkins Medicine, Promote and Protect Health